1.
Clin. biomed. res
;
42(3): 289-291, 2022.
Artículo
en Inglés
| LILACS
| ID: biblio-1416959
RESUMEN
We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management.